tiprankstipranks
Apyx Medical Announces Boardroom Overhaul and New Chairman
Company Announcements

Apyx Medical Announces Boardroom Overhaul and New Chairman

Pick the best stocks and maximize your portfolio:

An update from Apyx Medical Corporation (APYX) is now available.

Apyx Medical Corporation has undergone a significant boardroom change with the resignation of Andrew Makrides as director and Chairman, and the appointment of Stavros G. Vizirgianakis in his stead. Vizirgianakis, a seasoned investor and advisor in the medical device sector, will receive standard compensation for his new role and partake in the upcoming nomination for reelection. Additionally, he has agreed to cooperate with the board in selecting another mutually agreed-upon board candidate and to adhere to certain standstill restrictions until the 2025 Annual Meeting of Stockholders.

See more insights into APYX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyApyx Medical price target lowered to $4 from $6 at Craig-Hallum
TipRanks Auto-Generated NewsdeskApyx Medical Reports Q3 Results and Restructuring
TipRanks Auto-Generated NewsdeskApyx Medical’s Strategic Moves for Financial Stability
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App